by RSM US LLP | Dec 22, 2025
Insights and Resources < Back to Insights and Resources Tariff relief for Swiss-origin generic drugs: What importers need to knowARTICLE | December 22, 2025Authored by RSM US LLP Executive summary: Swiss-origin generic pharmaceuticals now exempt from reciprocal...
by RSM US LLP | Jun 16, 2025
Insights and Resources < Back to Insights and Resources Navigating tariffs and supply chain challenges in constructionARTICLE | June 16, 2025Authored by RSM US LLPTariffs and rising prices will impact segments of the construction industry differently, but no sector...
Recent Comments